TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50 | -66.2% | 5,958 | 0.0% | 0.01% | -64.7% |
| Q2 2023 | $148 | +19.4% | 5,958 | -27.7% | 0.02% | +13.3% |
| Q1 2023 | $124 | +63.2% | 8,243 | +27.6% | 0.02% | +36.4% |
| Q4 2022 | $76 | -99.8% | 6,458 | 0.0% | 0.01% | +83.3% |
| Q3 2022 | $38,000 | +40.7% | 6,458 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $27,000 | -59.1% | 6,458 | -6.4% | 0.00% | -50.0% |
| Q1 2022 | $66,000 | -42.6% | 6,897 | +13.5% | 0.01% | -42.9% |
| Q4 2021 | $115,000 | -30.3% | 6,076 | +22.8% | 0.01% | -39.1% |
| Q3 2021 | $165,000 | -6.2% | 4,946 | +9.0% | 0.02% | -11.5% |
| Q2 2021 | $176,000 | -19.6% | 4,536 | 0.0% | 0.03% | -31.6% |
| Q1 2021 | $219,000 | -7.2% | 4,536 | 0.0% | 0.04% | -17.4% |
| Q4 2020 | $236,000 | – | 4,536 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |